Bio-Rad Laboratories Inc (BIO)

Debt-to-assets ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 1,199,100 1,198,710 1,198,380 1,198,000 1,197,700 1,197,270 1,196,940 1,196,740 10,514 10,600 10,779 10,901 12,258 12,241 12,200 12,205 13,579 437,808 437,680 437,600
Total assets US$ in thousands 12,299,100 11,895,900 11,978,200 13,667,400 13,501,700 12,058,500 12,682,100 14,373,700 17,799,400 19,953,400 15,117,600 13,933,200 12,972,600 12,020,900 10,097,300 8,684,360 8,008,860 7,177,100 7,646,900 6,862,900
Debt-to-assets ratio 0.10 0.10 0.10 0.09 0.09 0.10 0.09 0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.06 0.06

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,199,100K ÷ $12,299,100K
= 0.10

The debt-to-assets ratio for Bio-Rad Laboratories Inc. has been relatively stable over the past eight quarters, ranging from 0.08 to 0.10. This ratio indicates the proportion of the company's assets that are financed through debt. A lower ratio typically suggests lower financial risk, as it implies that a smaller portion of the company's assets is funded by debt obligations.

Bio-Rad Laboratories Inc.'s consistent debt-to-assets ratio around 0.10 indicates that the company has maintained a prudent level of debt relative to its total assets. This suggests a healthy balance between debt and equity financing, which could be viewed positively by investors and creditors.

The slight increase in the debt-to-assets ratio from 0.09 in Q1 2023 to 0.10 in Q4 2023 may indicate a slightly higher reliance on debt financing during that period. However, since the ratio remains within a narrow range, it does not raise significant concerns about the company's overall solvency or financial stability.

Overall, based on the historical trend of Bio-Rad Laboratories Inc.'s debt-to-assets ratio, the company appears to have a conservative approach to debt management, which may contribute to its financial resilience and long-term sustainability.